Evaluation of Preeclampsia Patients – 3 Years of Data

Research Article

Abstract

Introduction: Preeclampsia is the most important cause of maternal, fetal, and neonatal morbidity and mortality worldwide, affecting approximately 4% of all pregnancies.

Objective: Patients admitted to our clinic and diagnosed with non-severe preeclampsia, severe preeclampsia, HELLP syndrome, and eclampsia were retrospectively examined, and the demographic, clinical, and laboratory data obtained from these patients were compared with the diagnostic groups.

Method: A total of 156 patients, including 63 with non-severe preeclampsia, 84 with severe preeclampsia, 6 with HELLP syndrome, and 3 with eclampsia, who were followed up and treated in our center, were evaluated. Patient characteristics were classified by comparing the groups regarding delivery methods, demographic characteristics, and clinical and laboratory parameters.

Results: In terms of maternal complications, peripartum hemorrhage and placental abruption were more common in the eclampsia and severe preeclampsia groups. At the same time, DIC was more common in the patient group diagnosed with HELLP syndrome, and these results were found to be statistically significant (p<0.05). When demographic, clinical, and laboratory data were compared with whether maternal complications developed, the rate of maternal complications was found to be significantly higher in patients with elevated AST and ALT. No maternal mortality occurred in any of the patient groups.

Conclusion: The higher rate of maternal complications in patients with elevated AST and ALT suggested that follow-up of this patient group in the intensive care unit will be beneficial in reducing maternal morbidity and mortality.